Characteristics | HAP (n = 94) | VAP (n = 117) | ||||
---|---|---|---|---|---|---|
Adequate treatment n = 43 (%) | Inadequate treatment n = 51 (%) | p | Adequate treatment n = 37 (%) | Inadequate treatment n = 80 (%) | p | |
Age (years) | 60.67 ± 16.04 | 65.14 ± 13.75 | 0.167 | 63.59 ± 16.65 | 63.85 ± 17.07 | 0.907 |
Sex (male) | 32(74.4) | 37 (72.5) | 1.000 | 24 (64.9) | 45 (56.3) | 0.497 |
Surgical unit | 9 (20.9) | 8 (15.7) | 0.697 | 21 (56.8) | 25 (31.3) | 0.015 |
Underlying diseases | ||||||
Diabetes mellitus | 5 (11.6) | 8 (15.7) | 0.789 | 5 (13.5) | 11 (13.8) | 1.000 |
COPD | 13 ( 30.2) | 10 (19.6) | 0.341 | 11 (29.7) | 17 (21.3) | 0.443 |
Chronic renal failure | 5 (11.6) | 4 (7.8) | 0.727 | 0 (0) | 3 (3.8) | 0.551 |
Congestive heart failure | 4 (9.3) | 9 (17.6) | 0.386 | 6 (16.2) | 13 (16.3) | 1.000 |
Cerebrovascular disease | 1 (2.3) | 9 (17.6) | 0.019 | 3 (8.1) | 15 (18.8) | 0.227 |
Malignancy | 6 (14.0) | 9 (17.6) | 0.838 | 6 (16.2) | 11 (13.8) | 0.944 |
Central venous catheterization | 16 (37.2) | 22 (43.1) | 0.710 | 30 (81.1) | 58 (72.5) | 0.442 |
Urinary catheterization | 33 (76.7) | 37 (72.5) | 0.820 | 37 (100) | 78 (97.5) | 1.000 |
Late-onset pneumonia | 34 (79.1) | 46 (90.2) | 0.223 | 34 (91.9) | 72 (90) | 1.000 |
Acquisition of other site infection | 12 (27.9) | 11 (21.6) | 0.637 | 11 (29.7) | 42 (52.5) | 0.036 |
Previous antibiotic usage | 20 (46.5) | 23 (45.1) | 1.000 | 11 (29.7) | 36 (45.0) | 0.173 |
MDR bacteria | 29 (67.4) | 38 (74.5) | 0.599 | 32 (86.5) | 60 (75) | 0.243 |
Polymicrobial etiology | 1 (2.3) | 8 (15.7) | 0.036 | 2 (5.4) | 6 (7.5) | 1.000 |
Length of stay before HAP | 7.6 ± 4.3 | 9.18 ± 5.8 | 0.194 | 13.89 ± 11.56 | 14.88 ± 10.34 | 0.313 |
APACHE II score | 12.7 ± 5.83 | 14.92 ± 5.83 | 0.031 | 16.08 ± 6.94 | 16.69 ± 6.72 | 0.654 |
Exitus | 16 (37.2) | 24 (47.1) | 0.452 | 27 (73) | 53 (66.3) | 0.608 |